GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (LTS:0RA2) » Definitions » Interest Expense

Poxel (LTS:0RA2) Interest Expense : €-6.27 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Poxel Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Poxel's interest expense for the six months ended in Dec. 2023 was € -2.72 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-6.27 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Poxel's Operating Income for the six months ended in Dec. 2023 was € -5.49 Mil. Poxel's Interest Expense for the six months ended in Dec. 2023 was € -2.72 Mil. Poxel did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Poxel Interest Expense Historical Data

The historical data trend for Poxel's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poxel Interest Expense Chart

Poxel Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 -1.56 -2.46 -3.81 -5.71

Poxel Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.55 -2.25 -2.99 -2.72 -3.55

Poxel Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-6.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Poxel  (LTS:0RA2) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Poxel's Interest Expense for the six months ended in Dec. 2023 was €-2.72 Mil. Its Operating Income for the six months ended in Dec. 2023 was €-5.49 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was €40.14 Mil.

Poxel's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Poxel did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Poxel Business Description

Traded in Other Exchanges
Address
259/261 Avenue Jean Jaures, Immeuble le Sunway, Lyon, FRA, 69007
Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.

Poxel Headlines

No Headlines